Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2656 of 5804
-
Can a placebo plus counseling beat cancer fatigue?
Symptom relief Recruiting nowTo find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to improve your quality of life better than either the psychoeducational interventions or the placebo alone.
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Laser light may ease back pain without drugs
Symptom relief OngoingThe purpose of this research study is to gather information on the effectiveness of the Trident low-level laser therapy (LLLT) in combination with clinical patient education manuals to reduce lower back pain.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Heart surgery patients may get new shield against dangerous rhythm
Prevention Recruiting nowThe purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New study aims to stop superbugs before they start
Knowledge-focused OngoingIn 2022, in collaboration between the Botswana Ministry of Health (MOH), the U.S. Centers for Disease Control \& Prevention, and the Botswana-UPenn Partnership (BUP), a program was launched called, "Surveillance of Healthcare-associated infections \& Antimicrobial Resista…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Shock therapy for leaky bladders: new device aims to dry up prostate cancer aftermath
Symptom relief Recruiting nowBackground: Men who are treated for prostate cancer often develop urinary leakage (incontinence). An experimental device that uses electrical impulses to stimulate pelvic floor muscles and surrounding tissues may help. Objective: To see if the Elidah device can reduce urinary …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Brain scans reveal how new combo drug curbs appetite
Symptom relief CompletedPart A: The study will look at participants appetite and energy intake and also look at the mechanisms of brain associated with appetite and food intake. Participants will not get any medicine and will be in a group that will be compared to another group receiving a weight-loss m…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New drug combo aims to tame cirrhosis complications
Disease control CompletedThis is a Phase IIb multicentre, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the safety of zibotentan/dapagliflozin in combination as compared to zibotentan monotherapy as well as zibotentan/dapagliflozin and zibotentan monotherapy as compared t…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for heart patients: drugs target hidden inflammation from blood mutations
Disease control CompletedThis Phase 2a clinical trial evaluated the effectiveness, safety, and tolerability of increasing dose strengths of an oral daily medication, DFV890, administered for 12 weeks, or a single s.c. dose of MAS825, to reduce key markers of inflammation related to CVD risk, such as IL-6…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Parkinson's patients try At-Home brain zaps to improve walking
Symptom relief CompletedThe purpose of this study is to investigate the efficacy and safety of self-administered transcranial direct current stimulation to improve the single- and dual-task gait in patients with Parkinson's disease.
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Vitamin e gel could stop Dupuytren's before fingers curl
Prevention Recruiting nowDupuytren disease (DD) is a common hand disorder with disabling finger contractures that may require surgery to restore function. In the early stages of the disease, the nodules (Tubiana stage 0) are usually painless, but a reason for concern to many patients. Not rarely, lifesty…
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Magic mushroom compound probes brain in FND patients
Knowledge-focused CompletedThe goal of this study is to learn about the brain network response in people who have functional neurological disorder who are administered with a single dose of the psychedelic psilocybin with therapeutic support. The main question it aims to answer is: Can the default mode n…
Phase: NA • Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could a probiotic boost fertility? new study investigates
Disease control Recruiting nowIn the last decades, numerous publications have broken the old paradigm that considered the urogenital tracts as sterile, demonstrating that microorganisms present in the urogenital tract represent the 9% of the whole human microbiome. Healthy urogenital microbiome improves impla…
Phase: NA • Sponsor: ProbiSearch SL • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Shining a light on PAD: simple home therapy could ease walking pain
Symptom relief OngoingThe LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related dama…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a Plant-Based compound boost good cholesterol in High-Risk patients?
Disease control Recruiting nowThe Investigators will test the hypothesis that 2-HOBA will reduce modification of HDL and LDL and improve HDL function in humans with heterozygous FH. The Investigators plan to first study subjects with Familial Hypercholesterolemia (FH), treating them with 750 mg of 2-HOBA or p…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a gentle zap to the neck help teens with POTS?
Symptom relief CompletedThe purpose of this study is to determine if nVNS will decrease autonomic symptom intensity (COMPASS-31 and Child Functional Disability Inventory) in adolescent patients with postural orthostatic tachycardia syndrome (POTS) in comparison to standard recovery STEPS management.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can a diabetes drug help hearts recover after valve surgery?
Disease control CompletedThe study is a randomized, placebo-controlled, and double-blinded trial in patients with aortic stenosis (AS) undergoing aortic valve replacement (AVR). After AVR, patients will be randomized 1:1 to empagliflozin (SGLT2i) or placebo to investigate whether empagliflozin is superio…
Phase: PHASE4 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a prostate cancer drug help women with fatty liver and PCOS?
Disease control Recruiting nowNonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are at disproportionate risk for NASH, with approximately 15 million U.S. women affec…
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common supplement ease jaundice? new trial investigates
Disease control CompletedInvestigating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice.
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Virtual reality could cure stage fright in just one session
Symptom relief TerminatedThis study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-wee…
Phase: NA • Sponsor: Vilnius University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Heart failure patients may finally ditch thirsty fluid rules
Knowledge-focused Recruiting nowHeart failure is the most common cause of admission to hospital and is associated with high morbidity and mortality. Treatment options consist of medical- and device treatment and self-care strategies, where fluid restriction has been one of the components in the self-care manage…
Phase: NA • Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC